Distributor inventory | Vial
Insulin Human (Biphasic) 30/70 Injection (30% soluble human insulin + 70% isophane/NPH human insulin), 40 IU/mL
Diabetes mellitus (Type 1 and Type 2) requiring insulin; control of blood glucose levels in patients needing a premixed insulin regimen
This is a premixed human insulin containing 30% short-acting (soluble) insulin for meal-time glucose control and 70% intermediate-acting (NPH/isophane) insulin for basal control. It lowers blood glucose by increasing peripheral glucose uptake and reducing hepatic glucose production.
For subcutaneous injection only as advised by a doctor (commonly 1–2 times daily, about 30 minutes before meals). Use a sterile insulin syringe calibrated for 40 IU/mL (U-40). Roll the vial gently between palms to resuspend (do not shake) until uniformly milky; check for clumps. Rotate injection sites; do not inject into a vein.
Common side effects of XSULIN 30/70 VIAL 40IU may include:
Risk of severe hypoglycaemia—monitor blood glucose, carry fast-acting sugar, and avoid skipping meals after dosing. Dose may need adjustment with changes in diet, activity, illness, kidney/liver impairment, or when switching insulin brands/strengths. Do not use if solution contains clumps/particles after proper resuspension or if expired. Use caution when driving/operating machinery if prone to low sugar. Not for IV use; mixing/switching should be done only on medical advice.
